Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa
Clinical trial NCT05322473 · COMPLETED
Trial details
- NCT number
- NCT05322473
- Sponsor
- MoonLake Immunotherapeutics AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-25
- Primary completion
- 2023-05-09
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.